NCT03938155 Women's Advanced Risk-assessment in Manitoba
| NCT ID | NCT03938155 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Boniface Hospital |
| Condition | Cardiovascular Disease (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-10-01 |
| Primary Completion | 2021-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-10-01 with a primary completion date of 2021-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is to test the ability of novel cardiovascular disease (CVD) prognostic tools to identify women at risk for future CVD. We plan to establish a cardiovascular health screening program at the St. Boniface Hospital and to test the efficacy of these tests for predicting adverse cardiovascular outcomes amongst a cohort of 1000 Manitoban women aged 55 years and older in the 5-year period after screening. A second purpose of this project is to identify novel CVD biomarkers that may indicate a person is at risk for cardiovascular disease. Therefore, we plan to ask participants for permission to collect and store a sample of both their blood and stool for future research.
Eligibility Criteria
Inclusion Criteria: * women aged 55 and older * possess a Manitoba Personal Health Information Number Exclusion Criteria: Previous hospitalization or treatment for: * Ischemic heart disease * Acute myocardial infarction * Stroke/Transient ischemic attack * Percutaneous coronary intervention * Coronary artery bypass surgery * Congestive heart failure * Peripheral artery disease * Congenital heart defects * Arrhythmia Additional exclusion: * Medical advice against physical activity * Previous participant in the Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease (NCT02863211)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03938155 clinical trial?
This trial is open to female participants only, aged 55 Years or older, studying Cardiovascular Disease (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03938155 currently recruiting?
Yes, NCT03938155 is actively recruiting participants. Contact the research team at tduhamel@sbrc.ca for enrollment information.
Where is the NCT03938155 trial being conducted?
This trial is being conducted at Winnipeg, Canada.
Who is sponsoring the NCT03938155 clinical trial?
NCT03938155 is sponsored by St. Boniface Hospital. The trial plans to enroll 1,000 participants.